ContextVision

Less than 1K followers

CONTX

Oslo Børs

Medical Equipment & Services

Health Care

Overview

Investor consensus

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

Market cap

-

Turnover

-

Revenue

120.53M

EBIT %

0.38 %

P/E

-

Dividend yield-%

-

Financial calendar

8/5

2026

Interim report Q1'26

12/5

2026

General meeting '26

27/8

2026

Interim report Q2'26

All

Press releases

ShowingAll content types

Regulatory press releaseyesterday

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release4/8/2026, 6:00 AM

ContextVision publishes annual report for the fiscal year 2025

Regulatory press release4/8/2026, 6:00 AM

ContextVision publicerar årsredovisning för verksamhetsåret 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release4/7/2026, 3:35 PM

NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)

Press release4/7/2026, 3:35 PM

KALLELSE TILL ÅRSSTÄMMA I CONTEXTVISION AB (PUBL)

Regulatory press release4/7/2026, 5:30 AM

ContextVision cancels market-making agreement

Regulatory press release3/26/2026, 4:20 PM

ContextVision AB: Transactions made under the buy-back programme

Press release3/26/2026, 12:00 PM

ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions

Regulatory press release3/17/2026, 6:05 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release3/6/2026, 7:48 PM

ContextVision AB: Transactions made under the buy-back programme

Press release3/2/2026, 6:30 AM

ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO

Regulatory press release2/25/2026, 4:04 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release2/19/2026, 9:02 AM

CONTX: Financial calendar

Regulatory press release2/19/2026, 7:00 AM

ContextVision AB: Year-end report 2025 – Substantial progress in transformation amid early signs of stabilization

Regulatory press release2/18/2026, 3:50 PM

ContextVision announces extended share buy-back programme

Regulatory press release2/16/2026, 4:16 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release2/5/2026, 4:00 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/27/2026, 4:17 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/16/2026, 4:26 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/7/2026, 5:36 PM

ContextVision AB: Transactions made under the buy-back programme

Forum discussions

Yleistä ContextVision AB (CONTX) on lääketieteellisiin kuva-analyysiratkaisuihin (algoritmeihin) erikoistunut yritys, ja sen liiketoiminnan ydintä ovat kuvankäsittely, tekoäly ja lääketieteellinen diagnostiikka sekä erityisesti näihin liittyvät ohjelmistoratkaisut. Yritys on sanojensa...

11/27/2023, 1:16 PM

by timontti

71

I also asked AI about the competitive landscape. There are plenty of them

11/27/2023, 5:33 PM

by timontti

6

Annual report published https://www.contextvision.com/contextvision-publishes-annual-report-for-the-fiscal-year-2023/ P.S. You can also add Norwegian companies to your watchlist through the Inderes service, even if they don’t have analyst coverage. At least you’ll get notifications...

4/12/2024, 9:07 AM

by timontti

3

Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.